Treatment Of Shallow Periodontal Pockets 4-6mm Using AIRFLOW Prophylaxis Master Device With Erythritol vs Manual Scalers
Launched by CAIRO UNIVERSITY · Apr 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for people with periodontitis, a gum disease that can lead to tooth loss. It compares the use of a special device called the AIRFLOW Prophylaxis Master, which uses a powder called erythritol to clean teeth, against traditional manual scalers. The goal is to see which method better reduces gum pocket depth, bleeding, and plaque, while also considering factors like patient comfort, satisfaction, treatment time, and costs.
To participate in this study, you need to be between 16 and 80 years old, have at least 20 teeth, and be diagnosed with periodontitis, meaning you have gum pockets that are 4 to 6 mm deep. You must also be generally healthy and able to attend follow-up appointments. The trial is currently recruiting participants, and if you join, you can expect to receive one of the two treatments and provide feedback on your experience. It’s important to note that pregnant women, those with certain health conditions, or severe respiratory issues cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Systemically healthy patients.
- • Patients with an age range between 16 to 80 years.
- • Patients have a minimum of 20 teeth.
- • Periodontitis patients with at least one residual pocket with a probing depth ranging from 4 to 6 mm.
- • Cooperative patients able and willing to come for follow up appointments.
- Exclusion Criteria:
- • Pregnant and lactation females.
- • Patients reporting systemic conditions (eg: diabetes).
- • Patients with severe or unstable upper respiratory tract infections, chronic bronchitis/asthma.
- • Patients with severe inflammation and/or osteonecrosis.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Cairo, , Egypt
Patients applied
Trial Officials
Hani El-Nahas, Professor
Study Director
Cairo University
Omnia Tawfik, Lecturer
Study Chair
Cairo University
Asim Al Ammour, Bachelor
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported